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Abstract 
Background: Women at high-risk of developing breast cancer must be screened appropriately 
and educated about breast cancer reduction strategies much earlier than those of average risk. 
The National Comprehensive Cancer Network (NCCN) (2017) has identified guidelines for the 
care of this group. While some primary care providers (PCPs) are well informed about high-risk 
and how to identify it, many are not. This project focuses on the development of education for 
providers, specifically an eLearning module, to help translate guidelines into practice. 
Methods: Providers of adult primary care (including internal medicine and family practice) from 
four clinics in Snohomish County, Washington, were asked to participate in an eLearning 
module regarding the care of patients at high-risk for breast cancer. The module was developed 
using the Microsoft Mix platform and a link was sent out to primary care providers via email 
during a thirty-day period.  Data was collected and analyzed using the Kirkpatrick Method to 
evaluate the objectives related to reaction, learning, behavior and results through a pretest survey 
and two posttests surveys (one immediately following the module and another approximately 
thirty days following the opening of the module) to determine if the objectives were achieved. 
Results: Repeated measures surveys using a Likert Scale were presented to the PCP participants, 
as well as questions regarding demographics and current practices.  The surveys assessed the 
four components of learning according to the Kirkpatrick Model including reaction, knowledge, 
behavior and results. Twenty-three providers (22.3%) responded and reacted positively to this 
learning format.  All participants reacted favorably to questions regarding reaction, with greater 
than 50% answering “strongly agree” or “agree”.  Paired t-tests were used to evaluate learning 
regarding knowledge and behavior, showing statistically significant improvement (sig. < 0.05) 
between pretest and posttest for questions about understanding current evidence-based 
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recommendations, use of a screening tool, and referrals to a breast care specialist, supporting      
that learning occurred and participants believed this learning would impact their behaviors.  
Results after one month were weak, with participation in the follow-up survey to be ten 
providers, however 60% were inclined to provide a more individualized approach to high-risk 
assessments, and 80% were more aware of the specialized care available to reduce the burden of 
high-risk care from their practices.  The use of a screening tool, as well as collaboration with 
experts, were two categories that remained neutral or showed little positive impact, however to 
truly evaluate these practices, a longer study would be beneficial.  
Implications for practice: High-risk breast education is needed for the PCP to engage in shared 
decision-making with their patients about high risk care. 
Conclusions: Patients at high-risk for developing breast cancer should be evaluated more 
frequently to prevent cancer.  The USPSTF does not set guidelines for mammography of patients 
who are at high-risk.  The NCCN (2016) has created evidence-based guidelines for the support 
and monitoring of patients who are found to be at high-risk; however, this evidence continues to 
be slowly disseminated.   
 
Keywords: High-risk, breast cancer, provider education, education module, internet-
based learning 
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Managing Patients at High-risk for Breast Cancer: A Learning Module for Primary Care 
Providers 
Introduction  
When making recommendations to patients about when they should be receiving their 
annual mammograms, it is often confusing for providers because various bodies of knowledge 
continue to disagree.  For women of average risk, The American Cancer Society (ACS), The 
American College of Radiology (ACR), The American College of Gynecology (ACOG) and The 
United States Preventative Services Task Force (USPSTF) do not agree on the starting age and 
frequency women should receive mammograms.  A majority of providers across the nation 
choose to follow the USPSTF recommendation who state that women should receive 
mammograms every two years after age 50-years until the age of 74-years (USPSTF, 2016).   
This recommendation differs from those of the ACS (2017) who recommend yearly 
mammography starting at age 45-years, and the ACR (2017) and ACOG (2017) who recommend 
yearly mammography starting at age 40-years.  In the midst of confusion about what is the best 
recommendation to follow for mammography, more recent evidence based recommendations 
regarding identification and management of patients at higher risk have not been uniformly 
translated into primary care.  This project focuses on educating primary care providers (PCPs) 
about recommendations for patients at high-risk for developing breast cancer, so that they can 
better educate their patients and facilitate shared decision-making about appropriate preventative 
care. 
Background 
Evidence indicates that persons of higher risk must be screened appropriately and 
educated about breast cancer risk reduction strategies earlier than persons at average risk.  The 
 7 MANAGING PATIENTS AT HIGH-RISK FOR BREAST CANCER  
high-risk category includes persons who have a strong familial history of breast and ovarian 
cancer, women with dense breast tissue, and those with genetic predisposition (Raikhlin et al., 
2015).  It is estimated that 86% of women over twenty years of age who have the BRCA1 and/ or 
BRCA2 gene mutations are unaware (Drohan, Roche, Cusack, & Hughes, 2012).  Additionally, 
in recent years, several new genetic mutations linked to breast cancer have been identified.  The 
guidelines created by the National Comprehensive Cancer Network (NCCN) (2017) for women 
at high-risk are more rigorous and include increased screening every six months alternating both 
mammography and magnetic resonance imaging (MRI), biannual breast examination by a breast 
care provider, and, where appropriate, genetic testing.  The consensus is that use of magnetic 
resonance imaging (MRI) is the most sensitive imaging modality in identifying cancer in earlier 
stages, when compared to using mammography alone (Berg et al., 2012).  
Furthermore, breast density is quickly becoming a recognized risk factor for breast 
cancer, however women generally do not know whether they have dense breast tissue until their 
first mammogram.  Thirty states have enacted laws requiring that breast density information be 
given to the patient following mammography (Vroomen, 2017), however Washington State is 
currently in process to do so.  The ACR (2014) supports that increased breast density may 
interfere with the detection of breast cancer and that is likely increases the risk of breast cancer, 
although breast tomosynthesis (3D imaging) mammography is improving the imaging of dense 
tissue.  
The NCCN (2017) guidelines are specific regarding the care of women with a greater 
than 20% lifetime risk, which often includes women under the age of 40-years. Unfortunately, at 
this time, these guidelines have not been translated into primary care practice very well.  While 
some primary care providers are very well informed about what qualifies a patient as high-risk, 
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others remain unsure.  Even when they are able to identify risk, they do not know how to manage 
or where to send these patients for further evaluation because high-risk breast programs are just 
beginning to emerge into mainstream health care.                    
The evidence-based guidelines that are in place to provide specialized care for these 
patients, however guidelines have not yet been well integrated into practice.  Providers need to 
be aware of what can be done to deliver optimal preventative care, or at the very least, how to 
appropriately screen and refer those most at risk. While high-risk breast programs are an 
emerging preventative service that may not be available in all areas, educating PCPs about these 
guidelines will better prepare them to assess risk and share in further decision making with their 
patients for the future (Cadiz et al., 2013).   
Problem Statement 
 Risk of undiagnosed breast cancer among women and men between the ages of 30-50 
years who have a greater than average risk for breast cancer, is indicated by breast cancer 
diagnoses among this population and partially-results from a delay in screening due to lack of 
provider knowledge about the need for early screening.  The goal of this project was to create, 
distribute and evaluate a relevant eLearning module that educates the primary care provider 
regarding specialized care of the high-risk population, and to affect a behavior change among 
PCPs to recognize their role in the preventative care of high-risk patients.   
Gap Analysis 
 This project focused on one community, Snohomish County, in Western Washington, 
approximately 20 miles north of Seattle.  One diagnostic breast center located in Everett, 
Washington, and serves patients in this community from two main medical groups, Providence 
Medical Group and The Everett Clinic, as well as two small practices, Seamar Medical Group 
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and Community Health Centers.  The breast center completes about 12,000 screening 
mammograms per year, and 12-15,000 diagnostic exams and procedures for patients including 
those referred in from other screening sites in the community.  The breast center also employs 
advanced practice nurses who are trained in providing evidence-based care for patients at high-
risk for breast cancer.  In 2014, the high-risk breast program launched, but referrals where less 
than 100 patients the first year, although they have steadily increasing over time. In the first eight 
months of 2017, nearly 500 patients had been seen in the high-risk program.  Approximately 
20% of these patients were referred by their PCP or obstetrician/ gynecologist who had previous 
knowledge of the program and the service it provides, while the other 80% were identified as 
potentially high-risk by the breast center staff during routine mammograms.  
Many of the patients referred to the high-risk program are identified at the breast center 
as potentially high-risk at the time of a routine mammogram.  Their brief health history is 
obtained and evaluated by the technologists and radiologists who perform and read the imaging 
exams mammograms.  The patient information is entered into the computerized mammography 
system which estimates a lifetime risk factor using the Tyrer-Cuzick and NCI lifetime risk 
models.  Once the risk has been calculated, the primary care providers are notified of the findings 
in the mammography report.  For those patients estimated to have a lifetime risk greater than 
20%, recommendations are made (in the mammography report), by the radiologist to the PCP, to 
refer the patient for a comprehensive risk assessment with the high-risk program providers.  The 
onus of this referral is placed back with the PCP to generate, as well as to share in the decision-
making with the patient about pursuing this care, as the radiologists do not manage on-going 
patient care.  The problem continues to be that many PCPs do not look for the recommendations, 
nor do they have knowledge regarding high-risk and what a high-risk program offers in 
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managing breast cancer prevention. 
Review of the Literature 
A search for literature related to the education of primary care providers about high-risk 
breast programs was conducted using the search engines CINAHL, PUBMED, The Cochrane 
Database and OVID.  Terms including “high-risk”, “breast cancer”, “internet-based learning”, 
“primary care providers”, “health care providers”, “continuing education”, “eLearning” and 
“modules” were used. Articles were considered if they were peer reviewed and published 
between 2007 and present.  The initial combined search for articles found 174 articles.  Articles 
were used as supporting evidence for this project if they identified high-risk breast programs as a 
resource for patients and providers, as well as those identifying a need for more of this 
knowledge in our community.  Articles were also included regarding the discussion of internet-
based learning among health care professionals, including the development and evaluation of this 
type of learning.  Literature was excluded if the article could not be easily retrieved related to 
cost or availability, was not peer-reviewed, did not include research pertaining to the holistic care 
of high-risk patients and/or programs (i.e. articles specific to cancer care or genetics only), or 
those that did not address the provider’s learning experience with at least part of the experience 
using an electronic format. 
Most of the information around high-risk breast care focused on the best imaging 
modalities for the detection of breast cancer, genetic involvement in breast cancer, and cancer 
care.  Although these topics are central themes in the care of high-risk patients, only six articles 
identified high-risk programs and the need for specialty care for high-risk patients. Evidence was 
found to support the idea that patients at high-risk benefit from a program that includes a 
comprehensive risk assessment, annual mammography and magnetic resonance imaging (MRI), 
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yearly office visits and clinical breast exam with a qualified provider, and genetic testing (if 
indicated) (Cadiz et al., 2013). Lifestyle modification education-including (but not limited to) 
diet/ exercise programs, stress-reduction methods, and smoking cessation plans-is also an 
important component of a high-risk program (Afonso, 2009).  
The benefit of high-risk programs does not appear to be widespread among primary care 
providers because literature supported that it was only after a cancer diagnosis was made that the 
patients were found to have genetic mutations and/or strong family histories of breast cancer, 
indicating provider education about identifying high-risk patients is currently subpar (Vanstone 
et al., 2012).  The USPSTF (2013) established guidelines for the primary care provider to 
appropriately screen and refer patients found to have a family history of breast, ovarian, tubal 
and peritoneal cancers for high-risk counselling; however, Quillin et al. (2013) found that only 
one in 22 patients who had such family histories was appropriately screened and referred by their 
PCP.  Another study identified that primary care providers have an interest in identifying and 
treating patients with risk, however they hesitate related to lack of knowledge (Gabram et al., 
2009). Kne et al. (2017) identified that the three contributing factors limiting the use of high-risk 
services include identification by the provider of high-risk patients, appropriate referrals to 
services for patients at high-risk, and follow through by the patient.  Brafford and Bush (2016) 
identified that the main reason for lack of compliance by the patient with high-risk care is the 
expense related to advanced imaging. 
The evidence is overwhelming that the PCPs must improve screening to capture and refer 
these patients.  It is expected that the patients will more readily follow the advice of their PCP if 
they engage in shared decision-making about a referral.  Once the patient has been identified and 
mutual agreement between the PCP and the patient is made about a referral to a high-risk 
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program, the high-risk team is in the unique position to take the burden of high-risk care from the 
PCPs and instead work in collaboration to meet the preventative care needs of the patient (Cadiz 
et al., 2013). 
Primary care providers in Snohomish County typically have twenty-minute appointments 
with each patient. It is difficult for the provider to gather all the necessary information about 
breast cancer risk in that time period, especially when patients present for other pressing health 
concerns.  Additionally, patients are not always prepared to answer detailed questions about 
family history during a short primary care visit.  Several websites offer education, guidance or 
tools to use in the care for the patients at high-risk.  Many screening tools have been developed 
for use during the PCP visit with the patient, but no specific tool has proven to be an 
overwhelming favorite (Quillin et al., 2013).  The Providence Health Systems Breast Cancer 
Clinical Practice Guidelines committee has created a tool (Appendix A), however it is not known 
to be widely used. To improve compliance with the use of screening tools in the primary care 
setting, education about high-risk, as well as information about local programs, must be 
delivered to the PCP to assist in the care of these patients. 
The review of literature search regarding high-risk breast programs produced no data 
regarding educational programs aimed at educating the health care provider or otherwise.  Five 
articles about the education of health care providers using eLearning programs were considered 
for this project, as they offered insight into developing a module about high-risk programs based 
on the experience of the authors in other areas of health care.  These articles discussed the format 
in which the authors used, as well as the tools they used to develop and evaluate their content.  
The experience of these authors (discussed below) was considered in developing this project. 
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A variety of educational platforms were used among different authors in creating learning 
opportunities for health care providers.  In each article reviewed, it did not appear that a common 
framework, specific to the learner population, was chosen, however each article reviewed 
appeared to have a holistic approach to their content design.  Each article discussed knowledge 
of the provider regarding the topic, but also included information about communication and 
behavior of health care profession in delivering care to the patient.   
One article described a study that used the Medscape Educational Platform (Buriak & 
Potter, 2013) to deliver an education module regarding cancer survivorship planning to 
multidisciplinary professionals including registered nurses, nurse practitioners and physicians.  
This type of study had high participation because it was open to various providers.  Another 
project that yielded good results used the American Association of Nurse Practitioners 
Continuing Education (AANP-CE) platform to educate nurse practitioners about culturally 
sensitive care concerning cervical cancer disparities among American Indian women (Peltier, 
2015). Delf (2012) described a process for educating non-medical personnel about bone scans 
using an independent virtual learning platform with software to build and deliver the program, 
which also showed promising results. 
  Finally, two articles offered educational opportunities to health care professionals with 
at least part of the experience completed in an on-line format.  Bryant, Puri, Dix, and Ahmed 
(2016) offered an in-person class for health care professionals, mainly midwives, about 
delivering patient education regarding Down’s Syndrome.  They used an on-line platform for 
surveying their population at three different intervals following the provider education.  Their 
results also showed good evidence that learning and behavior change occurred. Gregg and 
Twibell (2016) studied the effect of a program where graduate nursing students learned about 
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stress management strategies offered through on-line coursework at Ball State University.  
Following the class and some self-exploration of different methods, the participants were 
surveyed at different intervals to assess the effects. The project included learning, practicing and 
teaching components to allow for empathetic care of patients in the future by first discovering 
one’s own ability to manage stress (Gregg & Twibell, 2016).  Again, the results were positive. 
It is important to consider the tools these authors used to design and evaluate their 
programs for optimal learning.  Two articles discussed the use of the ADDIE (analysis, design, 
development, implementation and evaluation) instructional system model to develop their 
content (Buriak & Potter, 2013; Delf, 2012). Buriak and Potter (2013) also included the use of 
Mayer’s “Twelve evidence-based principles for multimedia-modality, interactivity and special 
contiguity” and Gagne’s “Nine Events of Instruction” to provide guidance in the development of 
an eLearning module while using anecdotal, case-based presentation of learning material.  It 
reached a wide variety of providers and concluded that this type of learning has the potential to 
reach around the globe delivering education while collecting data from different areas of 
practice.  Peltier (2015) used the Knowles’ five principles of adult learning to develop the 
presentation which was well received by nurse practitioners over a large geographic area in the 
United States; however, because it was offered through the AANP-CE platform, it was limited to 
nurse practitioners, and the few other disciplines who accessed the site for education materials.  
It was concluded that this material would benefit all types of providers, and therefore, should be 
shared through different platforms (Peltier, 2015).   
Three of the articles reviewed used the Kirkpatrick Model (2016) to guide the design and 
survey of the material, as it considers four elements of educational design which include 
reaction, learning, behavior and results.  Bryant, Puri, Dix, and Ahmed (2016) identified that 
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using the Kirkpatrick Model includes the identification of the learning objectives from an 
organizational perspective.  This is especially important because those who work with the 
implementation of evidence into practice are the experts, who by default, recognize the lack of 
knowledge among a community. Gregg and Twibell (2016) further added to this by including the 
most recent expansion to the Kirkpatrick Model which considers learner engagement and 
perceived relevance under the first element of reaction. Engagement and relevance of 
educational material are important factors to consider in changing behavior.  Delf (2012) 
identified that eLearning proved to be effective at renewing interest and insight into practice, 
thus changing behavior, which is the third element of the Kirkpatrick Model. Addressing the four 
elements of the Kirkpatrick Model in the development and analysis of eLearning appears to be 
an effective and useful tool that is often preferred especially in this type of learning environment.     
 When developing an eLearning module for educating PCPs about high-risk breast 
programs, it is important to use a platform that is accessible to all providers including physicians, 
nurse practitioners and physician’s assistants in one community.  Limiting this to one discipline 
will not achieve the desired outcome to educate and evaluate learning of all PCPs around this 
topic.  Evidence indicates that this type of education is needed in health care today, especially for 
all PCPs who are key stakeholders in identifying patients at high-risk.  It is also important to 
include guidelines or development methodology to ensure that content, objectives, and questions 
are created with the learner population in mind.  Using the Kirkpatrick Model allows for 
consideration of important elements of educational design to create effective learning 
opportunities for health care providers.  
Evidence Based Practice: Verification of Chosen Option 
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 The evidence-based practice guidelines that were reviewed and chosen for this project are 
those defined by the NCCN (2017) (Appendix B) for women with a greater than twenty percent 
lifetime risk of developing breast cancer.  The NCCN is comprised of world-renowned scientists 
and researchers who collaborate and review the latest evidence.  When creating and updating 
their recommendations, professionals gather from institutions around the globe to participate in 
an on-going and iterative process to set guidelines for clinicians to follow regarding cancer and 
risk.  The NCCN follows the same grading system as many other organizations setting guidelines 
based on clinical research and scientific evidence.  For the care of women at high-risk for breast 
cancer, their grade of the evidence is 2A: Based on lower-level evidence, the consensus of the 
NCCN team deems the interventions as appropriate (NCCN, 2017).  Recommendations in 
accordance with these guidelines include the following: 1. A clinical encounter every six to 
twelve months to begin at the age identified as being at higher risk, 2. Referral to a genetic 
professional if not already done, 3. Annual screening mammogram (preferably with 
tomosynthesis), 4.  Annual breast MRI, 5.  Consideration of risk reducing strategies, and 6. Self-
breast awareness enabling patients to promptly report any changes (NCCN, 2017).   
 Understanding that patients referred for high-risk care may incur the emotional stress and 
costs of increased screening (depending on insurance and coverage benefits), education to the 
provider will emphasize that prevention and early detection of breast cancer is proving to be 
beneficial for the high-risk group.  One systematic review showed that MRI alone increased 
sensitivity in detecting breast cancer, however centers employing strategies that include MRI, 
mammography, and clinical breast exam have shown sensitivity of 93-100% (Lord et al., 2007).  
A recent meta-analysis concluded that when screening patients of all ages with a strong familial 
history of breast cancer with both MRI and mammography, sensitivity increased to 98% (from 
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55% sensitivity with mammography alone); however, this may lead to decreased specificity and 
may increase false positives and over diagnosis (Phi et al., 2017).   
As evidenced by the literature, it is especially important for PCPs to know how to 
identify and refer patients who fall into the higher risk category to prevent over diagnosis.  This 
is the very reason screening recommendations exist for women at average risk, but also why 
there is so much controversy and disagreement among groups about screening for average risk.  
Experts agree that risk-based, individualized screening is important to reduce the burden of over 
diagnosis and diminish the morbidity of treatment (Monticciolo, Helvie, & Henrick, 2017).  In 
other words, it is crucial that PCPs and patients understand risk and how to best screen patients 
based on their risk.  The NCCN has created guidelines for high-risk patients because they benefit 
from additional screening efforts to prevent or catch cancer at an early stage.  Sharing this 
information through a learning module will prepare the PCP to identify and refer patients who 
qualify for this care. 
Theoretical Framework/Evidence Based Practice Model 
The Theory of Diffusion of Innovation was developed by Everett Rogers (2003) and 
describes the process by which to diffuse new knowledge to a social group.  It considers aspects 
of how to diffuse technology, or innovation, among groups.  Because the concept of high-risk 
breast programs is a fairly new one, an educational module was created for this project to assist 
providers in identifying patients at high-risk, and to help understand the recommendations and 
health management for these patients.  Rogers’ theory suggests that one key aspect of diffusing 
innovation is by forming early adopters to help spread new information among a population 
(Rogers, 2003).  Additionally, the theory discusses stages by which innovation is diffused among 
groups (Appendix C).  These steps include dissemination, adoption, implementation and 
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maintenance.  It is important to consider that educational modules must address key components 
of learning so that the learners will engage in the information and spread it amongst their social 
group.  Once full understanding about risk and appropriate care for those at high-risk becomes 
well recognized among providers and patients alike, the information will have successfully 
diffused among the population.   
Methods 
To provide a meaningful learning opportunity for the providers in the community about 
high-risk breast programs, this quality improvement project included the development of an 
internet-based education module that was delivered to PCPs of adult patients (including family 
practice and internal medicine).  The learning module was developed using the NCCN guidelines 
for high-risk individuals (National Comprehensive Cancer Network, 2017).  Early adopters of 
this innovation were identified as three physician leadership champions and one clinic manager 
champion.  One champion was located at each of the four sites who communicated with and 
encouraged PCPs to participate and learn this content in order to promote and support best 
practice.   
Goals and Objectives 
The goal of this project was to educate primary care providers about high-risk breast 
programs and how high-risk specialty care may serve as an adjunct in preventative care in 
collaboration with the PCP.  Understandably, PCPs have a number of priorities during an office 
visit.  Breast health is one of many items assessed during the routine health physical.  
Acknowledging this is necessary to gain the support of the PCP.  
The objectives for this project were developed considering the four elements of 
educational design including reaction, learning, behavior and results (Kirkpatrick, 2016).  The 
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objectives were: 1. Present information that is relevant and engaging to capture buy-in from 
PCPs, 2. Educate PCPs with evidence-based recommendations to give them the knowledge to 
engage in shared decision-making with their patients, and 3. Influencing the PCP’s behavior to 
appropriately refer patients to experts who will then reduce the burden of high-risk breast care on 
their practice.  The true organizational benefits from the accomplishment of these three 
objectives will be seen moving forward, as the time limits on this project cannot fully capture the 
extent of impact.   
Survey Design 
The Kirkpatrick model has previously been used for more than 50 years for survey 
design, many in health care settings, to evaluate goals and objectives, generating evidence 
beyond the learners’ behaviors and attitudes (Leslie et al., 2013).  Addressing reaction, an 
essential component of evaluation, gives the researcher insight and feedback regarding the 
participants attitude toward the learning modality; however, positive feedback does not 
necessarily indicate that learning has occurred (Rouse, 2011).   
The second level of evaluation addresses whether learning has occurred.  Learning is 
often determined best when a pretest and posttest are analyzed using a statistical test, such as the 
t-test; however, the acquisition of knowledge does not indicate that the behavior of the 
participant will change (Rouse, 2011).  Analysis of behavioral changes is the third level of 
evaluation using the Kirkpatrick Model.  The extent to which a participant applies their new 
knowledge and changes their behavior is key in successful project design (Bryant, Puri, Dix, & 
Ahmed, 2016).  Results can be measured only after the first three levels of learning have been 
addressed and adequate time has passed to observe results.    
. 
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Project Site and Population 
The project took place in Snohomish County, Washington.  The county has nearly 
780,000 residents, making it the third largest county in Washington with a predominantly 
Caucasian population (80%), but also including Hispanics (9%), Asians (10%), African-
Americans (3%) and Native Americans (1.5%) (Vance-Sherman, 2015).  Four large practices 
were chosen based on their practice locations (with more than two satellite clinics serving 
different areas of the county) and practice size (had at least 10 qualified providers.)  A total of 
103 providers were identified as eligible with one practice having 21 PCPs who were either 
internists or family practice providers, the second having 35 providers, the third having 34 
providers, and the fourth having 13 providers.    
Ethics and Human Subjects Protection 
 This eLearning project was reviewed by the University of Massachusetts Amherst 
Institutional Review Board and certified as exempt on January 17, 2018 (Appendix G).  The 
project did not involve contact with any patients.  Providers were contacted for participation via 
champions within their own organizations to allow for complete anonymity.  The DNP student 
was not notified of the names of participants by the champions.  The DNP student emailed a link 
to the champions who disseminated the link to the primary care providers of adult patients.  The 
link connected the participant directly to the module for anonymous completion.  No identifying 
information was collected from the participants.  All the results were collected by the Microsoft 
Mix platform in aggregate form.   
Results 
 The link to the eLearning module entitled “Identifying and Managing Patients at High-
risk for Breast Cancer”, with a pretest and posttest integrated into the format, was sent out to 103 
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PCPs in Snohomish county over a 30-day period.  Twenty-three (22.3%) participants completed 
the pretest, module and posttest.  There were no partially completed pretests or posttests, but 
there was a total of 33 views, indicating that the module was viewed but not completed by ten 
participants.  The follow-up survey link was sent out to the same group of participants via the 
clinic champions after the module closed.  It remained open for 30 days with a total of ten 
participants completing the survey. 
 The participants included advanced practice nurses (47%; n = 11), physicians (39.1%; n = 
9) and physician’s assistants (13.0%; n = 3).  The years of service for the participants was evenly 
distributed with 21.7% (n = 5) having practiced ten or more years, 26.1% (n = 6) having 
practiced 5-10 years, 26.1% (n = 6) having practiced 2-5 years, and 26.1% (n = 6) having 
practiced less than two years.  
Development of the learning module occurred between November and December 2017.  
The Microsoft Mix Platform was used to create the eLearning module because it is user friendly, 
allowed for anonymity, and allowed for easy integration of the pretest and posttest, as well as 
data collection.  Content slides (Appendix D) based on the objectives were created specifically 
for this module.  The module introduced the topic and information regarding implied consent, 
then proceeded to an integrated pretest, followed by 17 slides with learning content, then 
concluded with a posttest and evaluation.  The module was narrated but gave the participants the 
ability to proceed through slides at their own pace.  The entire length of the narrated module was 
six minutes, however the participants had the ability to move forward and backward as needed to 
review each slide.  In being mindful of limited time the PCPs may have to complete this module, 
the intent was that the participants spend the time they needed to complete the module, but not 
take more than an estimated 20 minutes.  
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Repeated measures surveys using a Likert Scale were presented to the PCP participants 
using questions that related to reaction, learning, behavior and results, as well as questions 
regarding demographics and current practices (Table 1).  
Table 1. Survey questions and relationship to Kirkpatrick model  
Model Level Questions Measure Survey 
1.  Reaction This training format was beneficial to my 
schedule. 
Five-point 
Likert-type 
categorical 
scale (strongly 
agree to 
strongly 
disagree) 
2 
 
This training is important for primary care 
providers. 2 
  
  
 
 
2.  Learning  I use a screening tool to identify risk. Five-point 
Likert-type 
categorical 
scale (strongly 
agree to 
strongly 
disagree) 
1, 2 
 
I understand current recommendations for 
high-risk patients. 1, 2 
 
I educate my patients regarding risk for 
breast cancer. 1, 2 
   
    
3.  Behavior I refer patients to experts for high-risk care. Five-point 
Likert-type 
categorical 
scale (strongly 
agree to 
strongly 
disagree) 
1, 2 
 
I engage my patients in shared decision-
making. 1 
 
I collaborate with experts regarding high-
risk care. 1 
   
  
 
 
4.  Results Since training, I more often refer patients 
for risk assessment. 
Five-point 
Likert-type 
categorical 
scale (strongly 
agree to 
strongly 
disagree) 
3 
 
Since training, my collaboration with 
experts has increased. 3 
  
This training has helped reduce burden on 
my practice. 
3 
 
There was a pretest (n = 23) before engaging in the learning section, a posttest (n = 23) and an 
evaluation immediately following the learning section.  It was accessible between February 1, 
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2018, and March 1, 2018.  A short follow-up survey (n = 10), to assess results related to 
behavioral change and patient care impact, was then conducted in the month following the initial 
learning module.  It was available March 1, 2018, through March 30, 2018, following the closure 
of the initial module.  The third survey did not take more than five minutes to complete.  Many 
of the questions in these surveys addressed the four levels of evaluation: reaction, learning, 
behavior and results, based on goals and objectives created by the DNP student and experts in 
the in high-risk breast care within the community.  Participants were asked about when they 
discuss breast cancer risk with their patients.  The majority, 65.2% (n = 15), answered that they 
address risk during routine physical exams, while 26.1% (n = 6) answered that they only discuss 
risk if the patient initiates it, and 8.7% (n = 2) answered that they only discuss risk when there is 
a breast issue.  None of the participants denied ever discussing risk with their patients.  The 
participants were also asked about which resources they use to assess patients for risk, with 
65.2% (n = 15) using the United States Preventative Services Task Force (USPSTF), 21.7% (n = 
5) using the American Cancer Society, and 13.0% (n = 3) not using any resources.  None of the 
participants use the National Comprehensive Cancer Network (NCCN) guidelines to guide risk 
assessment.   
 The reaction to the teaching module was overall positive.  Table 2 summarizes the results 
from the questions regarding the participants reaction to the module.  Questions assessed the 
participants beliefs about the material and the format in which the material was presented.  A 
Likert scale was used to rate answers as: Strongly agree (5), Agree (4), Neutral (3), Disagree (2), 
and Strongly disagree (1).   
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Table 2. Reaction to module  
(n = 23) 
Strongly 
agree 
n (%) 
Agree 
n (%) 
Neutral 
n (%) 
Disagree 
n (%) 
Strongly 
disagree 
n (%) 
Questions 
This training is beneficial to my 
schedule 
10 (43) 11 (47.8) 2 (8.7) 0 0 
Risk training is important for PCPs 11 (52.2) 11 (52.2) 0 0 0 
Material presented is relevant to my 
practice. 
10 (43.5) 10 (43.5) 3 (13) 0 0 
This learning improves the care I 
deliver. 
4 (17.4) 15 (65.2) 3 (13) 1 (4.3) 0 
This learning promotes collaboration 
among providers of care. 
1 (4.3) 15 (65.2) 7 (30.4) 0 0 
This learning enhances my awareness 
of resources in our community. 
0 13 (56.5) 7 (30.4) 2 (8.7) 1 (4.3) 
 
Although corresponding value for each answer was not needed for statistical analysis in this 
section, it was used for questions in upcoming sections.  Each question collectively scored over 
50% in the “Strongly agree” and “Agree” categories of the Likert Scale.  
 Repeated measure survey questions addressed the learning and behavioral components of 
the module.  To evaluate the statistical significance of learning and impact on behavior the 
participant gained from this module, a comparison of pretest and posttest answers in these areas 
were analyzed using a paired sample t-test with an alpha set at .05 to assess the null hypothesis 
that the 5-point Likert scale rating on the pretest is equal to 5-point Likert scale rating on the 
posttest.  Table 3 lists the topics of questions regarding knowledge and behavior, then gives the 
number of participant answers and percentage for each question from the pretest and posttest, 
and the paired t-test analysis of each category.   
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Table 3. Knowledge and behavior repeated measure analysis (n = 23) 
 
Pretest      
n,  (%) 
Posttest 
n,  (%) Mean 
Std. 
Dev. t df sig. 
Knowledge  
Understand recommendations   -0.8696 1.14035 -3.657 22 0.001 
   5-Strongly agree  2 (8.7) 5 (21.7)      
   4-Agree 3 (13.0) 14 (60.9)      
   3-Neutral 12 (52.2) 4 (17.4)      
   2-Disagree 6 (26.1) 0      
   1-Strongly disagree 0 0      
Educate patients about risk   -0.2174 1.1264 -0.926 22 0.365 
   5-Strongly agree  2 (8.7) 4 (17.4)      
   4-Agree 15 (65.2) 14 (60.9)      
   3-Neutral 3 (13.0) 4 (17.4)      
   2-Disagree 3 (13.0) 1 (4.3)      
   1-Strongly disagree 0 0      
Behavior  
Use of a screening tool   -1.4783 0.73048 -9.71 22 0.000 
   5-Strongly agree  0 0      
   4-Agree 1 (4.3%) 15 (65.2)      
   3-Neutral 4 (17.4) 8 (34.8)      
   2-Disagree 16 (69.5) 0      
   1-Strongly disagree 2 (8.7) 0      
Likelihood to refer for risk assessment  -1.3913 1.37309 -4.859 22 0.000 
   5-Strongly agree  2 (8.7) 4 (17.4)      
   4-Agree 0 14 (60.9)      
   3-Neutral 5 (2107) 3 (13.0)      
   2-Disagree 16 (69.7)  2 (8.7)      
   1-Strongly disagree 0 0      
Paired sample t-test with alpha set at .05 
 Two questions evaluated whether knowledge had been acquired after participating in the 
learning module.  The question asked the participants about understanding current 
recommendations for assessment of high-risk patients found there was a statistically significant 
difference, thereby rejecting the null hypothesis that learning would not be a significant 
difference between the pretest and posttest.  For the question regarding the education of patients 
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by the participant regarding high-risk, there was not a statistical difference between the pretest 
and posttest, thereby failing to reject the null hypothesis.   
 Two questions were used to evaluate the behavior of the participants, rather the 
confidence that the participant had that the learning would influence their behavior.  The first 
question was regarding the use of a screening tool in the practice setting, and the second question 
asked about the likelihood that the participant would appropriately refer for risk assessment.  
There was a statistically significant change from the pretest to the posttest, allowing the rejection 
of the null hypothesis that behavior change would not occur. 
 The participation in the follow-up survey was low (n = 10), but the results appear to be 
positive. The questions below (table 4) assessed whether the participants had sustained 
behavioral changes related to their learning.   
Table 4. Results follow-up survey  
Strongly 
agree Agree Neutral Disagree 
Strongly 
disagree 
Questions 
I more often consider individualized 
breast cancer risk for my patients. 
 
0 6 (60.0) 3 (30.0) 1 (10.0) 0 
I am now using an assessment tool to 
screen my patients for breast cancer 
risk. 
 
0 3 (30.0) 4 (40.0) 2 (20.0) 1 (10.0) 
I know what specialized resources are 
available to reduce the burden of high-
risk breast care on my practice. 
 
3 (30.0)  5 (50.0) 2 (20.0) 0 0 
My collaboration with experts/peers 
regarding patients at high-risk for 
breast cancer has increased. 
0 3 (30.0) 5 (50.0) 1 (10.0) 1 (10.0) 
    
The results of the follow-up survey after one month indicate that PCPs are more likely to 
consider individualized risk for their patients (60% favorable), and have knowledge about how to 
 27 MANAGING PATIENTS AT HIGH-RISK FOR BREAST CANCER  
reduce the burden of high risk breast care on their practice (80% favorable).  The use of a 
screening tool, as well as collaboration with experts about high risk care remained neutral. 
Discussion 
 This project provided an eLearning module to providers to help them understand the 
current recommendations regarding the patient at high-risk for breast cancer.  The objectives for 
this project were met through the presentation of information that was relevant and engaging to 
capture buy-in from PCPs. Primary care providers were educated about evidence-based 
recommendations to enable them to engage in shared decision-making with patients about high 
risk.  Additionally, PCP’s behavior was influenced to appropriately refer patients to experts who 
reduce the burden of high-risk breast care on their practice.  The participating PCPs, 22.3% of 
the identified population, were surveyed with a pretest and posttest built into an eLearning 
module. An additional follow-up survey was sent out 30 days after the initial module, of which 
9.7% participated.   
The reaction to the module from participants was positive.  Questions regarding reaction 
to the eLearning module were answered with the majority stating that the format was beneficial 
to their schedule, the training was important and relevant to their practice setting, the training 
improved care delivery, and that it enhanced resource awareness and collaboration.   
Kirkpatrick (2016) states that positive reaction to learning is crucial in successful 
learning, and eLearning appears to be a beneficial method of education for busy PCPs.  Despite 
the use of champions at each practice location, the participation by PCPs was not as high as 
anticipated.  The thought was that the ease in which the PCP population could access the 
modules on their own would positively influence participation.  The champions themselves were 
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busy practice leaders and likely did not continually remind their PCPs to take the survey as often 
as had hoped.   
Rogers’ theory (2003) discusses that adoption of innovation is a key step in diffusing it 
into a population, however it must be followed by implementation and maintenance, the third 
and fourth characteristics of the diffusion of innovation process.  While the champions were 
considered the early adopters, the implementation process needs more support to get the 
information out to a wider group of participants.  It does appear that a representative sample of 
PCPs participated proving that the education about high-risk breast care is lacking and needs to 
be diffused overall. 
Many of the questions help gain insight to the current practices of the PCPs in this 
community, including the engagement in shared decision-making with their patients.  The 
module educated the PCPs about the NCCN guidelines, educating their patients routinely, and 
offered guidance about using a tool and referring to specialists when needed.  Not many PCPs in 
this group were using a tool to help screen for high-risk patients, and none of the participants 
were using the NCCN guidelines to help guide their treatment of patients.  The lack of tool usage 
may be directly related to lack of valid tool availability; however, it may also be a cumbersome 
and time-consuming process.  While some tools used in health care have been validated and are 
used repeatedly, there has not been a standard tool developed for breast risk assessment.  The 
PCPs and patients are also bombarded with conflicting information about breast care from 
different organizations, so it is often difficult to understand what should be done.  The NCCN 
guidelines (2017) offer clear and concise direction for the treatment of patients, however the 
PCPs do not appear to consistently use these guidelines, as most appeared to follow the USPSTF 
guidelines. 
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  The eLearning module did positively impact the PCPs ability to engage with their 
patients.  Significant improvements in both knowledge and confidence in behavioral changes 
were observed.  This population now understands that the NCCN guidelines are a concise 
resource, are more likely to consider using a tool in their practice to screen for risk, and are more 
likely to refer for assessment with an expert.  Although the use of a tool and the willingness to 
collaborate remained neutral in the follow-up survey, this survey only captured a small number 
of participants.  The analysis between the pretest and posttest indicated a very significant 
improvement in willingness to use a screening tool and collaborate with an expert, however lack 
of a valid tool and limited breast care experts in the community are likely contributing to the 
neutrality of the follow-up survey answers.  Additionally, greater than one month may be needed 
to adequately assess the impact of the learning.    
The education of patients by the PCP was the only area tested where significant 
improvement was not observed following the learning.  This was an interesting finding because 
risk for breast cancer is not adequately addressed in the primary care setting according to the 
participants.  While the majority of this population screen for risk during the annual exam, 
approximately 35% do not address it yearly.  Breast cancer risk potentially changes yearly for 
patients related to health changes, family history changes, and age.   
Risk should be addressed yearly and patients must be aware of risk to ensure it is 
included in their routine care.  This must be an area of education that the PCP covers while 
assessing for other risks, although anecdotal evidence from patients suggests that discussion 
regarding the initiation of mammography is as far as the conversation goes between the patient 
and PCP in many instances.  This may be related to the numerous health topics that patients 
address with their providers in the limited time available during routine exams, however it 
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remains important for the provider to consider the patient’s personal and family history.  
Individualized risk assessment is necessary for thorough preventative care, and this appears to be 
a current deficit in primary care.  
Limitations 
The main limitation with this project was the lack of participation from providers.  
Education of the PCP regarding high-risk breast care was found to be valued, however the 
overall participation was expected to be higher, especially because each site had a champion to 
help spread the value of this education.  For future efforts in educating PCPs, incorporating more 
of an incentive should be used to entice more participation.  Continuing education credits 
combined with longer module availability may improve participation. It may also be helpful to 
understand if providers are currently bombarded with learning modules on various topics despite 
their convenience.   
 Changing the delivery of the education may be beneficial as well.  Although eLearning 
modules are often well-received related to their ease in access, in-person delivery of breast 
cancer risk education may be beneficial in capturing an audience, as well as answering questions.  
Given the length of the eLearning module, this information may be easily translated into a 
classroom format, thereby allowing brief teaching lessons during staff meetings or group 
learning opportunities. 
The comments made by a handful of participants at the final question of the evaluation 
included a few common themes.  Participants wanted a valid risk assessment tool to allow for 
ease in screening.  They also requested contact information for programs providing breast risk 
and genetic health assessments in our area, but this was not given related to the research process 
and unbiased approach to educating providers.  Perhaps providing a comprehensive list of all 
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programs within a demographic area would be appropriate for future researchers.  Two 
participants indicated wanting an open forum to ask questions; this reinforced the idea that an in-
person learning option would likely be beneficial.   
Conclusion 
Patients at high-risk for developing breast cancer should be evaluated more frequently to 
prevent cancer, or at minimum, detect cancer in early stages.  The USPSTF does not set 
guidelines for mammography of patients who are at high-risk, yet many PCPs are following the 
general guidelines for the average risk population.  The NCCN (2016) has created evidence-
based guidelines for the support and monitoring of patients who are found to be at high-risk, 
however, this evidence continues to be slowly disseminated.   
 This project aimed to educate primary care providers in one community about the science 
and value in high-risk breast programs.  Through the use of an eLearning module, PCPs gained 
understanding about to how best manage this patient population while ensuring preventative care 
guidelines through collaboration with experts.  Additionally, this education has shown significant 
improvements in knowledge and confidence in future behaviors, thereby empowering the PCP to 
engage patients in shared decision-making around preventative care for patients with high-risk 
for breast cancer.   
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Appendix A.  Providence Health System Breast Cancer Risk Screening Tool 
 
 
 
Breast Cancer Risk Screening Tool (Providence Health System, 2016) 
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Appendix B.  National Comprehensive Cancer Network Guidelines: Breast Cancer 
Screening and Diagnoses Version 1.2017 
 
 
Women who have a lifetime risk >20% as defined by models that are largely dependent on 
family history: 
• Clinical encounter every 6-12 months 
o To begin when identified as being at high-risk 
o Referral to genetic counseling if not already done 
• Annual screening mammogram 
o To begin 10 years prior to the youngest family member but not less than age 30 
years 
o Consider tomosynthesis 
• Recommend annual breast MRI 
o To begin 10 years prior to the youngest family member but not less than age 25 
years 
• Consider risk reduction strategies 
• Breast awareness 
Breast Cancer Screening and Diagnoses Version 1.2017 (NCCN, 2017) 
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Appendix C.  Roger’s Theory Components 
The Innovation-Decision Process (Dingfelder & Mandell, 2010) 
                                  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Dissemination 
Strategies to make 
potential adopters aware 
of innovation 
 
Adoption 
Commitment to begin 
using innovation 
(consider 5 variable) 
Implementation 
Putting innovation to use 
Maintenance 
Degree to which 
innovation is used over 
time. 
PERCEIVED CHARACTERISTICS OF THE INNOVATION: 
1. Relative Advantage 
2. Compatibility 
3. Complexity 
4. Trialability 
5. Observability 
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Appendix D. eLearning Module Slides and Follow-up Survey Outlines 
 MODULE 1.  Identifying & Managing Patients at High Risk for Breast Cancer 
An eLearning Module for Primary Care Providers 
 
Introduction & Purpose 
WHAT: Brief eLearning module for PCPs (this is approximately 20 minutes in length.)  
 
WHY: To gather info about current practices and inform PCPs about evidence-based guidelines.   
 
WHO: All PCPS in Snohomish County willing to participate. 
 
WHEN: Available for 30 days. A brief follow-up survey will be sent via email approximately 
one month following this initial survey. 
 
WHERE: You’re here! 
 
THANK YOU FOR PARTICIPATING!!! 
 
  
 
IMPLIED CONSENT 
You are being invited to participate in a research study titled Identifying and Managing Patients 
at High Risk for Breast Cancer.  This study is being done by Erin Chaney, BSN, RN, DNP 
student, from the University of Massachusetts Amherst.  You were selected to participate in this 
study because you are a primary care provider in Snohomish County, WA. 
  
The purpose of this research study is understand the current practices of primary care 
providers around the screening of patients at high risk for breast cancer, as well as to give 
education to primary care providers about the management of these patients in accordance 
with evidence-based guidelines.  If you agree to take part in this study, you will be asked to 
complete an online survey/questionnaire.  This survey/questionnaire will ask about current 
practices, personal knowledge about the topic, beliefs and actions you have about the care of 
this population, and the reaction you have to this type of learning.  It will take you 
approximately 20 minutes to complete. Approximately 30 days following this module, you will 
receive a link to a short follow-up survey via email.  This survey will take less than 5 minutes to 
complete. 
  
You may not directly benefit from this research; however, we hope that your participation in the 
study may will lead to the development of better screening practices and collaborative 
management of patients at high risk.   
  
We believe there are no known risks associated with this research study; however, as with any 
online related activity the risk of a breach of confidentiality is always possible.  To the best of 
our ability your answers in this study will remain confidential.  We have minimized any risks by 
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having your leadership distribute this module link to providers through email distribution lists 
and not including any questions that will lead to your identification.  Additionally, you have 
accessed this module within a cloud-based platform that does not record any information 
except your answers to the survey questions.  
  
Your participation in this study is completely voluntary.  By continuing with this module, you are 
consenting to participate. 
 
If you have questions about this project or if you have a research-related problem, you may 
contact the researcher, Erin Chaney, echaney@umass.edu, 425-346-5982, or, faculty advisor, 
Dr. Rachel Walker, PhD, RN, r.walker@umass.edu, 413-545-0250. If you have any questions 
concerning your rights as a research subject, you may contact the University of Massachusetts 
Amherst Human Research Protection Office (HRPO) at (413) 545-3428 or 
humansubjects@ora.umass.edu. 
 
Thank you for your participation in this research. 
 
PRETEST 
 
CONTENT 
 
WHEN TO START MAMMOGRAPHY? 
AVERAGE RISK 
USPSTF- Biennially at 50 years 
ACS- Annually at 45 years 
ACR- Annually at 40 years 
ACOG-  Annually at 40 years 
 
HIGH RISK 
USPSTF- May benefit from increase imaging 
ACS- Annual mammography and MRI 
ACR- Annual mammography and MRI 
ACOG- Annual mammography and MRI 
 
CONSIDERATIONS for DETERMINING RISK 
 
Personal History 
 
History of breast or ovarian cancer 
Age 
Chest wall radiation 
Dense breast tissue 
History of breast biopsy (for any reason) 
Ashkenazi-Jewish Decent 
Lifestyle  
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CONSIDERATIONS for DETERMINING RISK 
 
Family History 
 
Breast or ovarian cancer in any 1st or 2nd degree relative 
Age of family member at cancer diagnosis 
Known male breast cancer 
Limited family information (i.e. adoption) or limited female relatives 
Ashkenazi-Jewish Decent 
 
CONSIDERATIONS for DETERMINING RISK 
 
Genetic Mutations 
 
Known or suspected BRCA1/ BRCA2 mutation 
Other known or suspected genetic mutations including: ATM, CHD1, CHEK2, 
NBN, NF1, PALB2, PTEN, STK11, TP53 (p53) 
 
 
PCPs Role 
 
Breast Cancer Risk Screening Tool (Providence Health System, 2016) 
 
Consider USING a tool 
 
Considering Breast Density 
 
Breast Density Levels 
 
PATIENT EXPERIENCE WHEN REFFERED TO HIGH RISK PROGRAM 
 
MODELS USED TO CALCULATE RISK 
 
Meet with a breast care provider 
Risk factors considered and software used to calculate lifetime risk 
Greater than 20% lifetime risk is HIGH RISK 
Annual Imaging/monitoring and lifestyle modification education provided 
Genetic testing provided as indicated 
Referrals to surgeon (prophylactic surgery) and oncology (chemo prevention) as indicated 
 
 
Collaborative Care: DECREASING THE BURDEN OF CARE FOR PCPs 
 
COST OF CARE 
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CASE STUDY 
42-year-old, Caucasian female (no Jewish ancestry) visits her primary care for annual health 
check.  She mentions that her 72-year-old mother has recently been diagnosed with recurrent 
breast cancer with metastases following a two-year remission. No other breast or ovarian cancers 
in maternal family known, but one maternal uncle died from throat cancer, and her maternal 
grandfather died from lung cancer with brain metastases.  
Her paternal great-grandmother had breast cancer at age 55 years. Her paternal grandmother died 
of cancer at the age of 75 years, but the type of cancer was unknown (large abdominal tumors 
found just prior to death in 1993.) Her father has had basal cell carcinoma removed from his face 
in the past year.  Neither the patient’s father or grandmother had any female siblings. 
 
The patient has two young daughters with no other pregnancies. Prior to having children, she 
took oral contraceptives for 10 years.  She had a breast biopsy at age 18 years, which was a 
benign fibroadenoma.  No other health problems.  BMI is 38.   
 
Two years prior, she decided to have a mammogram despite her previous PCP telling her that she 
probably didn’t need to start screening mammography until age 50 years.  She was found to have 
heterogeneously dense breast tissue.   
 
WOULD YOU REFER THIS PATIENT FOR RISK ASSESSMENT? 
Case Study Continued… 
Risk assessment was discussed with the mammography technologist during her screening 
mammogram.  Because patient has sisters and daughters, she felt it was appropriate to follow-up 
with a risk assessment.  Additionally, she doubted that she was of average risk. 
After giving a thorough history to the nurse practitioner at the High-Risk Clinic, she was found 
to have a lifetime risk of 38%.  She then discussed this finding with her mother who confirmed 
that she had undergone genetic testing (following her second breast cancer diagnosis) and was 
found to not have any mutations.  The patient then contacted the High-Risk provider and gave 
this information.  The risk was recalculated and fell to 28%. 
The patient was informed that genetic testing would be appropriate given her father’s family 
history, however she decided to first ensure her life insurance policies were in order prior to 
testing. 
Although she has been determined to be at high risk for breast cancer, she will not need to start 
annual MRIs until age 45 years per NCCN guidelines.  She will, however, continue to be 
followed in the high-risk program with annual mammography, plus lifestyle modification 
including weight loss and exercise. 
 
THANK YOU 
 
YOUR PARTICIPATION IS GREATLY APPRECIATED 
PLEASE PROCEED TO THE POSTTEST AND EVALUATION 
 
POSTTEST 
 
In 30-60 days… 
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…You will receive another email link to a very short survey regarding this module, in an effort to 
assess whether this education impacted your practice.  
 
Your participation in the short follow-up will be greatly appreciated to complete this project.  
 
Thanks again! 
 
EVALUATION 
 
You are finished! 
 
 MODULE 2. Identifying & Managing Patients at High Risk for Breast Cancer 
 
Follow-up survey 
 
IMPLIED CONSENT 
You were being invited to participate in a research study titled Identifying and Managing 
Patients at High Risk for Breast Cancer.  This study is being done by Erin Chaney, BSN, RN, 
DNP student, from the University of Massachusetts Amherst.  You were selected to participate in 
this study because you are a primary care provider in Snohomish County, WA. 
  
The purpose of this research study is understanding the current practices of primary care 
providers around the screening of patients at high risk for breast cancer, as well as to give 
education to primary care providers about the management of these patients in accordance 
with evidence-based guidelines.  If you participated in the initial eLearning module (a link was 
sent to you approximately 30 days ago) please complete this brief follow-up survey.   
You may not directly benefit from this research; however, we hope that your participation in the 
study may will lead to the development of better screening practices and collaborative 
management of patients at high risk.   
  
We believe there are no known risks associated with this research study; however, as with any 
online related activity the risk of a breach of confidentiality is always possible.  To the best of 
our ability your answers in this study will remain confidential.  We have minimized any risks by 
having your leadership distribute this module link to providers through email distribution lists 
and not including any questions that will lead to your identification.  Additionally, you have 
accessed this module within a cloud-based platform that does not record any information 
except your answers to the survey questions.  
  
Your participation in this study is completely voluntary.  By continuing, you are consenting to 
participate. 
 
If you have questions about this project or if you have a research-related problem, you may 
contact the researcher, Erin Chaney, echaney@umass.edu, 425-346-5982, or, faculty advisor, 
Dr. Rachel Walker, PhD, RN, r.walker@umass.edu, 413-545-0250. If you have any questions 
concerning your rights as a research subject, you may contact the University of Massachusetts 
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Amherst Human Research Protection Office (HRPO) at (413) 545-3428 or 
humansubjects@ora.umass.edu. 
 
Thank you for your participation in this research. 
 
Follow-up Questions 
 
Considering the content of the eLearning module you reviewed within the past two months, 
please answer the following questions…  
 
THANK YOU 
YOUR PARTICIPATION IS GREATLY APPRECIATED 
AGGREGATE FINDINGS OF THIS RESEARCH WILL BE SENT TO YOUR 
LEADERSHIP FOR DISTRIBUTION FOLLOWING ANALYSIS. 
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Appendix E. Pretest and Posttest Questions 
Question Type Survey 
How often do you discuss risk 
regarding breast cancer with your 
patients? 
Multiple choice: 
a) During routine physical exam 
b) Only when the patient asks 
c) Only when there is a breast concern 
d) I never discuss risk 
1 
What resources do you use to 
determine breast cancer risk? 
Multiple Choice: 
a) USPSTF Guidelines 
b) ACS guidelines 
c) Institutional guidelines 
d) NCCN Guidelines 
d) Other:_________________ 
1 
REACTION 
This training was offered in a 
format that is beneficial to my 
schedule. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
2 
This training is important for 
providers in primary care. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
2 
LEARNING (Knowledge and Confidence) 
I use a screening tool in my practice 
to appropriately identify patients at 
high-risk for breast cancer. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
1, 2 
I understand the most current 
recommendations used to determine 
if patients are at high-risk for breast 
cancer. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
1, 2 
I appropriately educate my patients 
regarding high-risk. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
1 
This training has increased my 
knowledge to educate my patients 
about high-risk. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
2 
BEHAVIOR 
I am confident that I refer patients 
for risk assessment appropriately. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
1 
This training has increased my 
confidence about referring patients 
for high-risk assessment. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
2 
I routinely engage in shared 
decision making with my patients 
regarding breast cancer risk. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
1, 2 
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I often collaborate with experts 
regarding breast cancer risk.  
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
1, 2 
RESULTS (Institutional impact) 
Since receiving training, I more 
often refer patients for risk 
assessment at the Breast Center. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
3 
Since receiving training, my 
collaboration with experts/peers has 
increased. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
3 
I believe that training has given me 
resources to reduce the burden of 
breast care on my practice. 
Likert scale (strongly agree, somewhat 
agree, neutral, disagree, strongly 
disagree) 
3 
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Appendix F. Program Evaluation Questions 
1. How many years have you been a healthcare provider?   
              Less than 1 years 
  2-5 years         
  5+ years         
  Greater than 10 years 
 
2. What type of provider are you? 
 Physician 
 Advanced practice nurse (ARNP, FNP, AGNP, etc.) 
 Physician’s assistant 
 Other: ___________________ 
 
3.  Using the following scale, please rate (check the appropriate box) the following statements to 
best fit your evaluation of this educational offering:  
                                 
Question  
 
 
5-Point Likert 
Scale 
 
 
 
5=Strongly agree 
4=Agree, 
3=Neutral, 
2=Disagree, 
1=Strongly 
disagree 
The learning in this module 
is relevant to my practice. 
 
The learning in this module 
will improve the care I 
deliver to patients. 
 
This learning promotes 
collaboration among 
providers. 
 
This learning enhances my 
awareness of resources in 
my community. 
 
The author of this module 
demonstrates expertise of 
the subject matter. 
 
 
 
4.  How do you feel about this module and eLearning as a method of learning?  Please comment. 
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Appendix G.  Investigational Review Board (IRB) Approval 
 
 
 
 
University of 
Massachusetts Amherst 
108 Research Administration 
Bldg. 
70 Butterfield Terrace 
Amherst, MA 01003-9242 
Research Compliance 
Human Research Protection Office (HRPO) 
Telephone: (413) 545-3428 
FAX: (413) 577-1728 
Certification of Human Subjects Approval 
Date: January 17, 2018 
To: Erin Chaney, Nursing 
Other Investigator: Rachel Walker, Nursing 
From: Lynnette Leidy Sievert, Chair, UMASS IRB 
Protocol Title: Managing Patients at High Risk for Breast Cancer: A Learning Module for Primary Care Providers (IRB 17-206) 
Protocol ID: 2017-4408 
Review Type: EXEMPT - NEW 
Paragraph ID: 2 
Approval Date: 01/17/2018 
Expiration Date: 01/16/2021 
OGCA #: 
This study has been reviewed and approved by the University of Massachusetts Amherst IRB, Federal Wide Assurance # 00003909.  Approval is 
granted with the understanding that investigator(s) are responsible for: 
Modifications - All changes to the study (e.g. protocol, recruitment materials, consent form, additional key personnel), must be submitted for 
approval in e-protocol before instituting the changes.  New personnel must have completed CITI training.  
Consent forms - A copy of the approved, validated, consent form (with the IRB stamp) must be used to consent each subject.  Investigators must 
retain copies of signed consent documents for six (6) years after close of the grant, or three (3) years if the study is unfunded. 
Adverse Event Reporting - Adverse events occurring in the course of the protocol must be reported in e-protocol as soon as possible, but no later 
than five (5) working days. 
Completion Reports - Notify the IRB when your study is complete by submitting a Final Report Form in e-protocol. 
Consent form (when applicable) will be stamped and sent in a separate e-mail.  Use only IRB approved copies of the consent forms, questionnaires, 
letters, advertisements etc. in your research. 
Please contact the Human Research Protection Office if you have any further questions.  Best wishes for a successful project. 
